Back

CRTAC1-A reprograms extracellular matrix viscoelasticity to constrain glioma progression

RAKSHIT, S.; Singh, V.; Swadia, D.; SAHA, P.; Nath, D.; Deokate, N.

2026-05-09 cancer biology
10.64898/2026.05.06.723198 bioRxiv
Show abstract

Mechanical remodeling of the extracellular matrix (ECM) influences glioma progression, yet the molecular regulators that control tumor matrix mechanics remain poorly understood. By comparing low-grade gliomas (LGGs), associated with improved patient survival, with glioblastomas (GBMs), which carry a poor prognosis, we identified the cartilage-derived ECM protein CRTAC1-A as enriched in LGGs and significantly reduced in GBMs, with elevated expression correlating with improved patient survival. Restoration of CRTAC1-A suppressed glioma cell proliferation and invasion and enhanced temozolomide efficacy in three-dimensional tumor spheroid models. Mechanistically, CRTAC1-A directly interacts with collagen I and reorganizes collagen networks across multiple length scales, generating a mechanically compliant yet structurally resilient ECM with reduced stiffness, enhanced elastic recovery, and resistance to persistent remodeling. This viscoelastic normalization limits invasive remodeling while preserving matrix permeability and drug penetration. Together, these findings identify CRTAC1-A as a reversible regulator of tumor ECM mechanics that suppresses glioma malignancy.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.